Business Wire

Polpharma Biologics Group Announces That Its Joint Venture Bioeq Has Submitted a Biologics License Application (BLA) for Biosimilar Ranibizumab to the U.S. Food and Drug Administration (FDA)

Share

Polpharma Biologics Group announces that its joint venture company with Santo Holding (Strüngmann Group), Bioeq, has submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for their biosimilar candidate of the ophthalmological drug Ranibizumab (Lucentis®).

The reference product is a monoclonal anti-angiogenic antibody fragment (Fab) used to treat various types of macular-degenerative diseases such as neovascular (wet) age-related macular degeneration, diabetic retinopathy, macular edemas and myopic choroidal neovascularization. Worldwide, at least 25 to 30 million people are affected by age-related macular degeneration. The launch of a biosimilar Ranibizumab can increase market competition, reduce cost and expand patient access with proven analytical and clinical similarity to the original product. It works by inhibiting vascular endothelial growth factor (VEGF), which is responsible for the excessive formation of blood vessels in the retina.

Subject to FDA's approval of this BLA, the product will be exclusively commercialized by Coherus BioSciences, Inc. in the United States.

Said submission represents the most recent milestone for Bioeq's ranibizumab biosimilar program and compliments marketing authorization applications submitted to EMA and UK MHRA already in July this year.

Dr Joerg Windisch, CEO of the Polpharma Biologics Group, commented:

“The submission of a BLA to the FDA is a major milestone for any therapeutic and brings hope to patients across the US. This announcement carries a tangible promise of treatment choice and improved access to those who suffer from debilitating vision loss, including age-related macular degeneration. This is another representation of our commitment to providing safe and effective medicines to patients.”

1) Lucentis ® is a registered trademark of Genentech Inc.

About Ranibizumab biosimilar

The Ranibizumab biosimilar, previously designated as FYB201 (and also known as CHS-201), has been originally licensed from Formycon AG (FRA: FYB/ WKN A1EWVY), a leading German biosimilars company, and subsequently developed by Bioeq AG, a joint venture between Polpharma Biologics and Santo Holding AG (Strüngmann Group). Phase III clinical trials for FYB201 have clinically demonstrated that the efficacy of FYB201 in patients with nAMD is comparable to that of Lucentis®.

About biosimilars

Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access. Biosimilars exhibit proven analytical and clinical similarity to their respective branded reference products.

About Polpharma Biologics Group

The Polpharma Biologics Group creates quality biosimilars with a passion to improve lives of patients. The group has built an extensive and growing pipeline of biosimilars to treat a number of medical conditions across major therapeutic areas. Several of these biosimilar assets have already been commercially partnered with the world’s largest biopharmaceutical companies.

The group operates a network of state-of-the-art development and manufacturing facilities across Europe, actively investing in technology, people and know-how, employing over 800 specialists from around the globe.

Learn more at www.polpharmabiologics.com

About Bioeq

Bioeq is a Swiss biopharmaceutical joint venture between the Polpharma Biologics Group and the Strüngmann Group. Bioeq develops, licenses and commercializes biosimilars.

www.bioeq.ch

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Joseph Reeds
Head of Marketing, Polpharma Biologics
Joseph.reeds@polpharmabiologics.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

NIQ-GfK Wins Radio and TV Measurement Contracts in South Africa15.10.2025 12:00:00 EEST | Press release

NIQ (NYSE: NIQ), a leading consumer intelligence company, is proud to announce that the Broadcast Research Council of South Africa (BRC) has appointed GfK, an NIQ company, to provide comprehensive measurement of radio and television audiences nationwide. This milestone marks a new era for South African media, marketing, and advertising, empowering the industry with robust, innovative, and actionable audience data. Following a rigorous and competitive selection process, the BRC first awarded the Radio Audience Measurement System (RAMS) contract to GfK in June 2025. The first round of radio data collection is already underway and initial insights will be released in Q1 2026. In addition, GfK will also design and deploy South Africa’s new Total Video Measurement service, aligning the country’s TV currency with the way audiences consume content today. Gary Whitaker, CEO of the BRC, commented, “We are pleased to partner with GfK and NIQ for the next chapter of audience measurement in South

Bentley Systems Advances Infrastructure AI with New Applications and Industry Collaboration15.10.2025 10:53:00 EEST | Press release

Bentley Systems’ Year in Infrastructure 2025 – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today unveiled new infrastructure AI capabilities at its Year in Infrastructure conference. Bentley also announced an Infrastructure AI co-innovation initiative, inviting engineering firms and asset owners to collaborate on the next generation of AI workflows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015714746/en/ Bentley's OpenSite+, the first engineering application leveraging generative AI for civil site design, is now in limited availability. It delivers projects up to 10 times faster without sacrificing accuracy. (Image courtesy of Bentley Systems) “AI is poised to transform infrastructure,” said Bentley CEO Nicholas Cumins. “At Bentley, our vision is for AI to empower infrastructure engineers—not replace them. Trustworthy AI, built on infrastructure context, can improve e

Bentley Systems Announces Bentley Infrastructure Cloud Connect15.10.2025 10:51:00 EEST | Press release

(Bentley Systems’ Year in Infrastructure 2025) – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced Bentley Infrastructure Cloud Connect, the new foundational layer of Bentley Infrastructure Cloud. Connect provides a connected data environment and unified experience for infrastructure professionals interacting with project and asset data, improving collaboration across the infrastructure lifecycle and value chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015261978/en/ Bentley Systems announced Bentley Infrastructure Cloud Connect, providing a trusted foundation to connect data and people across the infrastructure lifecycle and value chain. (Image courtesy of Bentley Systems) “Infrastructure data lives everywhere—in models, PDFs, inspection forms, photos, IoT sensors, and more—and it’s rarely connected,” said Julien Moutte, chief technology officer, Bentley S

Bentley Systems Bolsters Cesium with Reality Modeling Capabilities, Brings Geospatial Context to Infrastructure Engineering15.10.2025 10:50:00 EEST | Press release

(Bentley Systems’ Year in Infrastructure 2025) – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the availability of reality modeling services in Cesium, advancing its open platform for the built and natural environment. It also unveiled geospatial capabilities for project delivery and asset performance and a new immersive engagement application for infrastructure teams and stakeholders, all powered by Cesium. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015286327/en/ Bentley announced the availability of reality modeling services in Cesium, advancing its open platform for the built and natural environment. (Image courtesy of Bentley Systems) Since acquiring Cesium a year ago, Bentley has made significant progress in integrating technologies from both companies, powering its own products and empowering developers to build applications that visualize infrastru

SkySparc Acquires Inovotek Solutions to Strengthen Its Capital Markets Expertise and Expand Delivery Across Murex, Calypso, and FIS Platforms15.10.2025 10:00:00 EEST | Press release

SkySparc, a trusted global provider of digital transformation solutions for treasury and finance institutions, today announced the acquisition of Inovotek Solutions (“Inovotek” or the “Company”), a specialist provider of transformation services to capital markets and financial institutions. Financial terms were not disclosed. The acquisition will bolster SkySparc's position as a premier provider of comprehensive digital transformation services to capital markets clients globally. It will address critical client challenges, including regulatory compliance and complex re-platforming initiatives. Additionally, SkySparc will expand its expertise across leading trading and risk management platforms such as Murex, Calypso, and FIS. By combining Inovotek’s program management expertise with SkySparc’s established managed services and proprietary software – OmniFi and Optimizer – the Company will deliver a robust and complete offering capable of addressing the most complex and demanding client

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye